(Q51791744)

12 April 2018

title

Genetic moderators of naltrexone's effects on alcohol cue reactivity. (English)

1 reference

12 April 2018

0 references

John E McGeary

1

1 reference

12 April 2018

Peter M Monti

2

1 reference

12 April 2018

Damaris J Rohsenow

3

1 reference

12 April 2018

Jennifer Tidey

4

1 reference

12 April 2018

Robert Swift

5

1 reference

12 April 2018

Robert Miranda

6

1 reference

12 April 2018

publication date

1 August 2006

1 reference

12 April 2018

Alcoholism: Clinical and Experimental Research

published in

1 reference

12 April 2018

volume

30

1 reference

12 April 2018

issue

8

1 reference

12 April 2018

page(s)

1288-1296

1 reference

12 April 2018

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Mu opioid receptor gene variants: lack of association with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Effects of tobacco deprivation on alcohol cue reactivity and drinking among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Effects of naltrexone on alcohol self-administration in heavy drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Naltrexone increases the latency to drink alcohol in social drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Using acquired knowledge and new technologies in alcoholism treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Carbamazepine and cocaine-cue reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Reactivity of alcoholics and nonalcoholics to drinking cues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Alcohol urge and plasma beta-endorphin change after alcohol challenge with naltrexone pretreatment in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Relevance of cue reactivity to understanding alcohol and smoking relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Craving: consensus of status and agenda for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

What place does naltrexone have in the treatment of alcoholism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Cue reactivity as a predictor of drinking among male alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Reliability of alcohol abusers' self-reports of drinking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2006.00156.X

10.1111/J.1530-0277.2006.00156.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

release_3eyeph2qcff4lmxi2x7jeocs5e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3eyeph2qcff4lmxi2x7jeocs5e

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16899031

1 reference

12 April 2018